HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endophthalmitis Caused by Streptococcus:Clinical Outcomes and Antimicrobial Susceptibilities 2014-2019.

AbstractBACKGROUND AND OBJECTIVE:
To report the clinical settings, antibiotic susceptibilities, and outcomes of streptococcal endophthalmitis.
PATIENTS AND METHODS:
Retrospective case series evaluating culture-positive streptococcal endophthalmitis from January 1, 2014, to December 31, 2019.
RESULTS:
Thirty-eight eyes met study criteria. The most common clinical setting was post-glaucoma surgery (33.3%, 12/36). The most frequent isolate was Streptococcus viridans (63.2%, 24/38). Isolates were susceptible to vancomycin (100%, 36/36), ceftriaxone (100%, 28/28), and levofloxacin (100%, 36/36). Final best-corrected visual acuity was 20/150 or better in 24.1% (7/29) but 20/200 or worse in 75.9% (22/29). Enucleation was performed in 11.1% (4/36). A subset (n = 11) of cases were evaluated for streptococcal-specific virulence factors: pneumolysin was present in 18.2% (2/11), autolysin in 45.5% (5/11), and hyaluronidase in 54.5% (6/11). Clinical setting, antibacterial susceptibilities, timing of pars plana vitrectomy, and virulence factor presence were not associated with better visual outcome or enucleation rate (P > .05).
CONCLUSION:
Visual prognosis for streptococcal endophthalmitis is poor despite early and appropriate antibiotic treatment. [Ophthalmic Surg Lasers Imaging Retina. 2021;52:182-189.].
AuthorsPatrick C Staropoli, Harry W Flynn Jr, Darlene Miller, Patrice J Persad, Elizabeth A Vanner
JournalOphthalmic surgery, lasers & imaging retina (Ophthalmic Surg Lasers Imaging Retina) Vol. 52 Issue 4 Pg. 182-189 (04 2021) ISSN: 2325-8179 [Electronic] United States
PMID34039183 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Anti-Bacterial Agents
  • Anti-Infective Agents
Topics
  • Anti-Bacterial Agents (pharmacology, therapeutic use)
  • Anti-Infective Agents
  • Endophthalmitis (diagnosis, drug therapy)
  • Eye Infections, Bacterial (diagnosis, drug therapy)
  • Humans
  • Microbial Sensitivity Tests
  • Retrospective Studies
  • Streptococcus
  • Visual Acuity
  • Vitrectomy
  • Vitreous Body

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: